Clinical Trial Update: Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and preliminary activity of an rHSA/GCSF fusion protein in breast cancer patients with chemotherapy-induced neutropenia; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Neutropenia

Drugs mentioned

• rHSA/GCSF Fusion Protein (recombinant human serum albumin granulocyte colony-stimulating factor fusion protein)

Snippet

Sponsor: Tianjin SinoBiotech Ltd. | Conditions: Chemotherapy-induced Neutropenia, Cancer, Breast | Phase 1 | Status: COMPLETED